| P2093 | author name string | Sarah E Hoffe | |
| | Thomas J Dilling | |
| P2860 | cites work | Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer | Q28248396 |
| | Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer | Q28272711 |
| | Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study | Q33257944 |
| | Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer | Q33495634 |
| | Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 |
| | Trends in long-term survival following liver resection for hepatic colorectal metastases | Q34523502 |
| | Solitary colorectal liver metastasis: resection determines outcome | Q34567525 |
| | Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 |
| | Analysis of clinical complication data for radiation hepatitis using a parallel architecture model | Q36716395 |
| | Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study | Q36866000 |
| | Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy | Q39465773 |
| | Analysis of radiation-induced liver disease using the Lyman NTCP model. | Q44048914 |
| | Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame | Q45157055 |
| | Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer | Q46390560 |
| | Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial | Q47311333 |
| | Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients | Q48410030 |
| | Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience | Q48747629 |
| | Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. | Q52142739 |
| | Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. | Q53519999 |
| | Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. | Q53598674 |
| | Oligometastases. | Q55065168 |
| P433 | issue | 2 | |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 104-111 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Cancer Control | Q15724614 |
| P1476 | title | Stereotactic body radiation therapy: transcending the conventional to improve outcomes | |
| P478 | volume | 15 | |